.@nymag and @nicholsonbaker8: This article is filled with wild speculation about SARS-CoV-2's origins and signifies a lack of understanding around basic genetics and viral evolution. nymag.com/intelligencer/…
The story cherry-picks from research and statements prior to 2020 to make the same misconceived arguments about SARS-CoV-2 bioengineering that have been debunked repeatedly for nearly a year. nymag.com/intelligencer/…
Ex. The story pulls this quote from Feb 2020, saying a coronavirus is “unlikely to have four amino acids added all at once"

Just last month, we learned of two variants w/ 17 and 10 similar changes arising naturally in the UK and South Africa, respectively nymag.com/intelligencer/…
Aside from the scientific mistakes, the story primarily quotes sources that have long been peddling the lab-release theory of SARS-CoV-2's origins. It is one of the most unbalanced articles that I've ever read. I can't believe that you've picked it as your cover story.
.@NYMag claims "its fact-checking team spent a month vetting the story" and that two molecular biologists "provided critical feedback to help ensure the accuracy of the work"

I find that surprising, given the story is missing basic counterexamples...
For example, this study from July predicts the lineage behind SARS-CoV-2 has been circulating unnoticed in bats for decades. Just wondering if you caught it? #AskingForAFriend
nature.com/articles/s4156…
Truly @NYMag, you could have contacted @stgoldst, so that he could explain some of the strong evidence against the bioengineered origins of SARS-CoV-2 in the space of three tweets
That's the thing, @Ayjchan. The @nymag/@nicholsonbaker8 article doesn't just speculate.

Its primary takeaway is that the SARS-CoV-2 was bioengineered, even though it doesn't objectively present the evidence to the contrary.
.@R_H_Ebright: Just because you say “something is *possible*” doesn’t mean “it is probable.”

As a seasoned scientist, you’re likely familiar with the value of this distinction...
Likewise, I am familiar with your reputation for Twitter discourse aka insults, so here’s a rapid-fire list of flaws with @nicholsonbaker8’s piece for @NYMag and with your collective reasoning.
1) Nicholson says his central assertion “isn’t a conspiracy theory. It’s just a theory.” This is incorrect.

By alleging without verifiable proof that the researchers were willfully involved with bioengineering SARS-CoV-2, he peddled a conspiracy theory.
pbs.org/newshour/scien…
2) Next, let’s go to Merriam-Webster’s definition of debunk, which means “ ***to expose*** the sham or falseness of…”

In other words, it doesn't mean “to rule out.”... merriam-webster.com/dictionary/deb…
...and so yes, there are plenty of debunkers about the "SARS-CoV-2 was manufactured" conspiracy theory.
the-scientist.com/news-opinion/t…

cidrap.umn.edu/news-perspecti…

snopes.com/news/2020/07/1…

nationalgeographic.com/science/2020/0…
3) Nicholson’s breakdown of the furin cleavage site begins by obfuscating basic counterpoints to his position.

If I may clarify: The feature isn’t found in SARS/SARS-like bat viruses, but something similar is seen in MERS...aka a coronavirus from bats related to SARS and SARS2.
4) Next, there is this quote from Feb 2020.

This quote’s inclusion and the subsequent takeaway are surprising, given that a June study of bat coronaviruses from Yunnan, China reported a three–amino acid insertion at the same site: cell.com/current-biolog…
This June study doesn’t seem to be on the radar of Yuri Deigin (@ydeigin), the biotech entrepreneur whose writing on SARS-CoV-2 is described as “lucid” by the @NYMag cover story.
5) Another curious observation: Yuri published an essay two months ago that is strikingly similar to the @NYMag cover story, both in terms of content and structure.

I would share it here, but I’m sure NY Mag’s weeks of editing and fact-checking noticed the similarities.
Yet another surprise: Yuri’s essay cherry-picks, too.

One of its early lines says the Wuhan market had been dismissed as a source of the outbreak... citing a WSJ article that stated both the market AND the Wuhan Institute of Virology had been ruled out. wsj.com/articles/china…
6) And once again, Nicholson’s takeaway about the furin cleavage site, as written, is that SARS-2’s “natural mutations were smaller and more haphazard,” which is illogical given the amino acid changes observed in two recent variants...
...and given that the SARS-CoV-2 lineage has circulated in the wild for decades aka had ample time to adapt naturally.
7) Does @nicholsonbaker8's cover story for @NYMag present any recent evidence of an accidental release involving a coronavirus? I read examples from 20 years ago involving SARS1.

I see cherry-picked safety assessments from 2004, which are likewise outdated...
...And I see plenty of speculation centered on circumstantial wire cables from 2018 about BSL-4 labs, even though *CORONAVIRUS RESEARCH ISN’T CONDUCTED IN BSL-4 LABS!*
Truly, did Nicholson find any indication that a laboratory accident involving a coronavirus happened anywhere in 2019? Or in the last five years? The last 10 years?

This story is supposedly an investigation. Did the writer look into it?
I suspect the answer is “no,” hence why this story resorts to listing out convoluted speculation about bioengineering.

Remove the speculative parts from @NYMag's cover story, and what would even be left?
8) There are fundamental errors of fact. For example, the SARS-1 pandemic started in 2002, and yet the story says:
9) The story is astoundingly one-sided.

Weeks of writing/editing/fact-checking, and Nicholson couldn’t find a single evolutionary biologist to discuss the natural adaptation of SARS-CoV-2? You spoke with Ralph Baric by phone, but did you discuss this topic in-depth with him?
10) Along those lines, @Ayjchan and @R_H_Ebright:

If you made an observation in the lab that contradicted your hypothesis, would you willfully omit/ignore the data in order to keep presenting the idea as plausible?
.@Ayjchan: You claim that this NY Mag piece is suitable Gonzo journalism.

My Q: Why would you, as a scientist, ever want to see a non-objective take of technical evidence in a public setting? Doesn’t that defeat the purpose of the scientific method and empirical research?
12) All of which brings us back to having confidence in “what’s possible” versus “what’s probable”

First, a quick sidebar:

Do you believe in the existence of black holes?
Technically, there is no direct evidence for a black hole. Even this photo from 2019 could be considered an indirect measure.

Yet we have strong "indirect" evidence pointing to the existence of black holes, hence why scientists and the lay public think that black holes exist.
With SARS2, you claim there is no evidence for its zoonotic origins because the virus hasn’t been isolated from a bat or intermediate animal host.

Related Q, @Ayjchan: In July, you said you're familiar with stories about Ebola spilling over from animals.

That is surprising...
...because the Zaire ebolavirus wasn’t detected in bats until January 2019--years after the start of recent outbreaks and decades after the virus's emergence. nytimes.com/2019/01/24/hea…
Indeed @Ayjchan, there are no documented cases of direct bat-to-human transmission of Zaire ebolavirus.

However, there is plenty of robust “indirect” evidence involving immunology and epidemiology. nature.com/articles/s4159…
So, when you claim SARS-CoV-2 is manufactured, you’re simultaneously disregarding the boatload of indirect evidence that shows the virus arose naturally...outside of a lab...without manipulation.

That’s what is unscientific and unbalanced about your words. Good day to you.
Ok, let's continue:

Honestly @Ayjchan, I'm starting to believe that you didn't read Nicholson's story all the way to the end...
At this point @Ayjchan and @R_H_Ebright, what are you even trying to say to me? And your disregard for genomic observations/Evo bio findings remains stunning and unscientific.
Finally, the takeaway about the three-amino-acid insertion isn't from friends of the author--but rather, a completely separate research group.
advances.sciencemag.org/content/6/27/e…
We’re only 5 days into 2021, and we have a contender for the worst/funniest takes of the year.
Ruh-roh: He doesn’t know the difference between an evidence-based review/analysis and an op-ed. 🙈

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Nsikan Akpan, PhD

Nsikan Akpan, PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MoNscience

4 Jan
Hey, that's me!

I've been hired by New York Public Radio (@WNYC/@Gothamist) to edit/run its Health & Science desk.

I'm excited to join @audreyhasnews, @jenchung, and all my new colleagues on their mission to revolutionize local news and cover the Empire State.
For those unacquainted with my backstory, I spent more than a decade in NYS/NYC for undergrad and graduate school.

So, it pained me last year to watch from afar as COVID-19 ripped through New York... Image
...I feel honored for the opportunity to cover the region as it moves forward into 2021 and beyond.

Moreover, the tri-state area is ground zero for some of the best research in the country. I'm excited to uncover those science stories and share 'em with everyone.
Read 6 tweets
30 Dec 20
The UK authorized the AstraZeneca-Oxford COVID-19 vaccine. Monumental!

But the BIGGER news centers upon the UK's changes to vaccine schedules. They will now allow people to delay their 2nd doses for up to 12 weeks.

Here's why that might be a gamble...
gov.uk/government/new…
1. UK's announcement came with some new data about the AstraZeneca-Oxford vaccine, which are summarized in this regulatory document:
assets.publishing.service.gov.uk/government/upl…

Chief among them is that a single-dose showed 73% efficacy against COVID-19 after nearly a month...
...hence why the Joint Committee on Vaccination and
Immunisation says "the second dose of the AstraZeneca vaccine may be given between 4 to 12 weeks following the first dose."

That's fine and dandy. The weird part centers around the UK's decision with the Pfizer vaccine...
Read 8 tweets
29 Dec 20
To my fellow journalists: If we can walk and chew gum, then we can write headlines without creating false dichotomies.

Even if touching a contaminated surface is a *less frequent* route of coronavirus spread, it *IS STILL* a route of coronavirus spread.
I fault the last 20+ years of intense political partisanship. It has bred a habit of boiling down everything into this versus that.

A citizen is either a liberal or a conservative. An attacker is either a lone wolf or a terrorist. Apple or PC. Team Jacob or Team Edward.
Science, especially health, operates with few true dichotomies. Coronavirus risk is relative, and good hygiene has been a pillar of public health since the bubonic plague.
Read 4 tweets
29 Dec 20
Public Health England has released new details on the UK coronavirus variant, including preliminary findings on its severity.

The report shows that the variant causes as many hospitalizations and deaths as the wild-type virus. assets.publishing.service.gov.uk/government/upl…
👍: The variant isn’t more severe.

👎: The variant still seems to spread faster/cause more cases, which could mean more hospitalizations and deaths overall. The new analysis reports the variant’s secondary attack rate is 15.1% versus 9.8% in the wild-type virus.
On the bright side: The UK variant doesn’t seem to cause more reinfections than wild-type.
Read 4 tweets
20 Dec 20
This story is wild!

The day after Thanksgiving, Dr. Deborah Birx (of the WH coronavirus task force) traveled to one of her vacation properties in Delaware. She was accompanied by three generations of her family from two households... apnews.com/article/travel…
It's wild because a week before Thanksgiving, Dr. Birx said that people need "limit interactions [to] indoors, to immediate households when we see this level of community spread." rev.com/blog/transcrip…
Receipts!
Read 5 tweets
20 Dec 20
Fact check: The U.S./CDC has NOT set its full prioritization plan yet, expect for recommending that HCWs and residents of long-term care facilities should receive the first doses (phase 1a)...
The CDC A*C*IP panel is meeting today/right now to decide the other phases i.e., it hasn't voted or come to a decision yet.

People can literally download the slide presentations (cdc.gov/vaccines/acip/…) or watch along (ustream.tv/channel/VWBXKB…)....
Among those slides, an onlooker ::coughs::@NateSilver538::coughs:: will find a slide that shows the ACIP's proposal *IS* to prioritize phase 1a --> 1b --> 1c by age...
cdc.gov/vaccines/acip/…
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!